BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 10563430)

  • 1. Radiotherapy in the treatment of primary central nervous system lymphoma (PCNSL).
    Nelson DF
    J Neurooncol; 1999 Jul; 43(3):241-7. PubMed ID: 10563430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole brain radiotherapy improves survival outcomes in primary CNS lymphoma patients ineligible for systemic therapy.
    Song J; Samant R; Jay M; Chaudry H; Fan XY; MacDonald D; Bence-Bruckler I; Nair V
    Support Care Cancer; 2020 Nov; 28(11):5363-5369. PubMed ID: 32140974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of radiation therapy in primary central nervous system lymphoma : KROG 14-20 Collaborative Study of Brain and Lymphoma Committee.
    Koh HK; Kim IH; Kim TM; Lim DH; Oh D; Cho JH; Kim WC; Kim JH; Chung WK; Jeong BK; Kang KM; Hong S; Suh CO; Kim IA
    J Neurooncol; 2017 Dec; 135(3):629-638. PubMed ID: 28939931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term remission of primary central nervous system lymphoma by intensified methotrexate chemotherapy.
    Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T; Fukushima T
    J Neurooncol; 2003 May; 63(1):87-95. PubMed ID: 12814260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong correlation between imaging response and survival among patients with primary central nervous system lymphoma: a secondary analysis of RTOG studies 83-15 and 88-06.
    Corn BW; Dolinskas C; Scott C; Donahue B; Schultz C; Nelson DF; Fisher B
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):299-303. PubMed ID: 10802352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHOD/BVAM regimen plus radiotherapy in patients with primary CNS non-Hodgkin's lymphoma.
    Bessell EM; Graus F; López-Guillermo A; Villá S; Verger E; Petit J; Holland I; Byrne P
    Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):457-64. PubMed ID: 11380234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of non-Hodgkin's lymphoma of the central nervous system with BMPD chemotherapy followed by radiotherapy.
    Korfel A; Thiel E
    Leuk Lymphoma; 1998 Aug; 30(5-6):609-17. PubMed ID: 9711923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial-brain radiotherapy for primary central nervous system lymphoma: multi-institutional experience.
    Iwabuchi M; Shibamoto Y; Sugie C; Ayakawa S; Ogino H; Baba F
    J Radiat Res; 2016 Mar; 57(2):164-8. PubMed ID: 26661856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective phase II trial of response adapted whole brain radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma-analysis of acute toxicity profile and early clinical outcome.
    Adhikari N; Biswas A; Gogia A; Sahoo RK; Garg A; Nehra A; Sharma MC; Bhasker S; Singh M; Sreenivas V; Chawla R; Joshi G; Kumar L; Chander S
    J Neurooncol; 2018 Aug; 139(1):153-166. PubMed ID: 29633112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is reduced-dose whole-brain radiotherapy also feasible in primary CNS lymphoma for curative or salvage purpose?
    Ko MK; Kwak YK; Choi BO; Jeun SS; Park JS; Ahn S; Song JH
    J Neurooncol; 2023 Nov; 165(2):321-328. PubMed ID: 37964132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of temozolomide plus concurrent whole-brain radiation followed by TNV regimen as adjuvant therapy for patients with newly diagnosed primary CNS lymphoma.
    Wang Y; Liu B; Xu D; Zhao H; Zhu Y; Xu J; Tao R
    Neurol India; 2013; 61(3):260-4. PubMed ID: 23860145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole brain radiation dose reduction for primary central nervous system lymphoma patients who achieved partial response after high-dose methotrexate based chemotherapy.
    Park JS; Lim DH; Ahn YC; Park W; Kim SJ; Kim WS; Kim K
    Jpn J Clin Oncol; 2017 Nov; 47(11):995-1001. PubMed ID: 28973509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparable outcomes of radiation therapy without high-dose methotrexate for patients with primary central nervous system lymphoma.
    Ishikawa H; Hasegawa M; Tamaki Y; Hayakawa K; Akimoto T; Sakurai H; Mitsuhashi N; Niibe H; Tamura M; Nakano T
    Jpn J Clin Oncol; 2003 Sep; 33(9):443-9. PubMed ID: 14594937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival following radiotherapy and cytarabine chemotherapy for sporadic primary central nervous system lymphoma.
    Pöttgen C; Stuschke M; Stüben G; Schmitz A; Schwechheimer K; Wacker HH; Rauhut F; Kleuker S; Wilhelm H; Grehl S; Fehlings T
    Strahlenther Onkol; 2003 Sep; 179(9):626-32. PubMed ID: 14628129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
    Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
    Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
    Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances for the treatment of primary central nervous system lymphoma (review).
    Yamanaka R; Tanaka R
    Oncol Rep; 2004 Sep; 12(3):563-8. PubMed ID: 15289838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy is effective as early treatment for primary central nervous system lymphoma.
    Boiardi A; Silvani A; Pozzi A; Fariselli L; Broggi G; Salmaggi A
    J Neurol; 1999 Jan; 246(1):31-7. PubMed ID: 9987711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy?
    O'Neill BP; O'Fallon JR; Earle JD; Colgan JP; Brown LD; Krigel RL
    Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):663-73. PubMed ID: 7558957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.